Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Research Writing · Optoelectronic applications

Applications of Optoelectronic Devices in Biomedicine: Imaging, Sensing and Phototherapy

An optoelectronic device converts between light and electrical signal, and in biomedicine it performs one of three functions: it detects light that has interacted with tissue, delivers light to tissue, or both. Most reporting deficiencies in this literature arise from treating light as a setting rather than as a dose; wavelength, irradiance and duty cycle are the parameters that make results comparable.

Pubrica AcademyWritten by the medical writing and biostatistics teams Reviewed byPubrica biostatistics team Published9 October 2026 Last checked9 October 2026 Reading time14 minutes Sources26 peer-reviewed

Pulse oximetry, photoplethysmography, fluorescence imaging, optogenetic stimulation, and photodynamic and photothermal therapy represent the same class of engineering problem viewed from different perspectives: a source, a tissue path and a detector. Reviewers of work involving any of these devices consistently ask the same questions: which wavelength, at what irradiance, for how long, measured where, calibrated against what, and in which skin or tissue types. This article covers the application space and the parameters that must be reported.

Learning objectives

  • What counts as an optoelectronic device in biomedical use, and the three roles they occupy
  • Why wavelength selection in optical sensing follows from tissue absorption, with the standard wavelengths and detector ranges
  • What flexible and wearable optoelectronics have achieved — power, strain tolerance and device density
  • What implantable optical stimulation requires, including the thermal constraint that limits it
  • How mature the underlying emitter technology is, including where efficiency falls off with area
  • What a methods section must specify so an optical measurement or exposure can be reproduced

Common misconceptions

  • “Red light” or “near-infrared” is a sufficient description. Such a description is insufficient. Pulse oximetry uses red and infrared light at 660 nm and 940 nm specifically, as Lee and colleagues note in Applied Sciences, because those wavelengths lie on either side of the haemoglobin isosbestic region. A band name is not a parameter.
  • “LED power rating describes the exposure.” Drive power is not the delivered dose. The relevant quantities are irradiance at the tissue surface in W/cm², duty cycle and total exposure time, which is why the photothermal figure of 0.15 W/cm² reported by Zheng and colleagues is expressed as a power density rather than a wattage.
  • “Implanted light sources heat tissue unacceptably.” This is not necessarily the case. Huang and colleagues, in the Journal of Semiconductors, report a brain-implanted micro-ILED with a temperature rise below 0.1 degrees C at 20 Hz stimulation; however, the figure is specific to that duty cycle, which is why duty cycle must be reported.
  • “Efficiency demonstrated on a small test device scales to a usable area.” Frequently it does not. Sun and colleagues, in Light: Advanced Manufacturing, report perovskite LED external quantum efficiency of 22.5% at 102 mm² falling to 21.46% at 900 mm², and 16.4% for a large-area green device over up to 9.0 cm².
  • “Photoplethysmography accuracy is a solved engineering problem.” The systematic review by Lee and colleagues screened 639 papers across five databases and selected 15, which indicates how limited the comparable evidence base is.

Definition and roles of optoelectronic devices in biomedicine

An optoelectronic device converts electrical signal into light, or light into electrical signal, or both. In biomedicine the useful classification is by role rather than by physics.

Detection. A photodiode or photodetector measures light that has passed through or been reflected from tissue. The quantity of interest is a change in absorption or scattering — arterial pulsation, oxygen saturation, glucose-related absorption, fluorophore emission. Kim and Baek, in Electronics, give a comprehensive review of photoplethysmography in wearable devices covering the technology, the current limitations and the open directions 11.

Emission. An LED, micro-LED, OLED or laser diode delivers light to tissue to drive a biological effect: optogenetic activation of channelrhodopsin, photodynamic therapy via a photosensitiser, photothermal conversion, or photobiomodulation. Cho and colleagues, in Materials Horizons, review flexible and wearable OLEDs for biomedical applications; Huang and colleagues, in the Journal of Semiconductors, cover micro-LEDs from implantable optogenetics to theranostics 3,4.

Both, co-located. The fastest-moving area is integrated source-and-detector systems: a patch that illuminates and measures, or a closed-loop implant that senses neural activity and stimulates in response. Metuh, Petersen and Ou, in Laser & Photonics Reviews, review wireless optoelectronic biomedical implants, and Zhao’s chapter on optogenetic implants in the Handbook of Biochips covers the implanted stimulation case 6,17.

The role of the device determines what must be reported. A detector requires specification of its spectral response, geometry and calibration; an emitter requires wavelength, irradiance at tissue, duty cycle and thermal behaviour.

Wavelength selection in optical sensing and tissue absorption

Photoplethysmography measures the pulsatile change in light absorption caused by arterial blood volume, and every aspect of device design follows from the absorption spectra of oxyhaemoglobin, deoxyhaemoglobin, water and melanin. Lee and colleagues, in Applied Sciences, set out the practical consequences: silicon photodiodes respond from 190 nm in the ultraviolet to 1100 nm in the infrared, and pulse oximeters typically use red and infrared light at 660 nm and 940 nm 19. The two wavelengths are chosen because oxyhaemoglobin and deoxyhaemoglobin absorb differently on either side of their isosbestic point, so the ratio of the two pulsatile signals maps onto saturation 19.

The clinical motivation is substantial. Wu, Wang and Shen, writing in the Journal of Materials Chemistry C, note that about 15 million people die worldwide from cardiovascular disease each year, which is the motivation for continuous flexible photoplethysmographic monitoring rather than intermittent measurement. They also report a self-powered flexible triboelectric nanogenerator reaching a maximum output voltage of 74.3 V, which indicates the direction of development for untethered wearables 9.

This enthusiasm warrants caution. Lee and colleagues’ systematic review of skin-compatible wearable photoplethysmography sensors screened 639 papers across five databases and selected 15 for inclusion 19. A selection ratio of that order usually reflects heterogeneous reporting rather than poor science: devices described without wavelength, without detector area, without contact pressure or without validation against a reference method cannot be compared, so they cannot be included. This is a reporting problem that the field can resolve, and it is the reason for the reporting guidance set out below.

190–1100 nmspectral response range of silicon photodiodes, UV to infrared
660 / 940 nmred and infrared wavelengths typically used in pulse oximetry
639 → 15papers screened across five databases, and papers meeting inclusion criteria

Source: Lee I, Park N, Lee H, Hwang C, Kim JH, Park S. Systematic Review on Human Skin-Compatible Wearable Photoplethysmography Sensors. Applied Sciences. 2021;11(5):2313.

Achievements of flexible and wearable devices

The engineering target for a wearable optoelectronic patch is a device that conforms to skin, survives deformation, consumes little enough power to run from a small source, and still delivers a uniform optical field. Huang and colleagues, in the Journal of Semiconductors, report specific figures: a skin-like optoelectronic health patch operating at a total power consumption of 16.5 mW under 30% tensile strain, and a uniform area-source patch integrating 900 thin-film micro-LEDs in a 2 × 2 cm² area 3. Both figures warrant careful reading: the first because power consumption under strain, rather than at rest, is the operationally relevant figure, and the second because a dense array is the means by which optical uniformity is achieved across a curved surface without hotspots.

Cho and colleagues, in Materials Horizons, review flexible and wearable OLEDs for biomedical applications, where the attraction is intrinsic conformability and diffuse emission and the limitation is lifetime and encapsulation under mechanical and moisture stress 4. Kim and Baek, in Electronics, cover the photoplethysmography side of the same device class and are explicit about what remains unresolved: motion artefact, contact pressure dependence and performance variation across skin tones 11.

This last point should be stated explicitly rather than implied. Optical absorption by melanin changes the signal reaching the detector, and a device validated on a narrow range of skin tones has not been shown to work generally 11,19. The skin tone distribution of participants should be reported using a stated scale; a study that does not report it is incomplete regardless of its accuracy figures.

Implantable optical stimulation and thermal constraints

Implanted light sources are used to stimulate genetically targeted neurons, and the technical constraints are power delivery, biocompatible encapsulation and heat. Zhao, in the Handbook of Biochips, covers optogenetic implants; Metuh, Petersen and Ou, in Laser & Photonics Reviews, review wireless optoelectronic implants, where removing the tether removes the main source of infection and tissue damage but introduces power-transfer and thermal-management problems 6.

Heat is the binding constraint, because neural tissue responds to temperature and a thermal effect would confound the optical one. Huang and colleagues report a brain-implanted micro-ILED showing a temperature rise below 0.1 degrees C at 20 Hz stimulation 3. The figure is reassuring but conditional: it is tied to that pulse frequency, and raising frequency, pulse width or optical power raises the thermal load 3. The reporting consequence is that an optogenetics methods section without the duty cycle — frequency, pulse width and total stimulation duration — has not reported the thermal exposure, and a reviewer cannot judge whether an observed behavioural effect was optical or thermal. A thermal control, such as stimulation in an animal without the opsin, is the standard approach and should be reported.

Encapsulation and long-term stability are concurrent considerations. An implanted device presents a material selection problem as much as an optical one, and biological evaluation follows the contact-and-duration logic of ISO 10993-1 and the FDA guidance on its use, with biodegradation testing treated as essential beyond 30 days of implantation as Al-Zyoud and colleagues note in Materials 1,3,8.

Phototherapy and light as the delivered dose

In photodynamic, photothermal and photobiomodulation applications the light is the therapeutic agent, which makes the dosimetry the core of the methods rather than a detail. The complete specification of an optical dose is wavelength and spectral bandwidth, irradiance at the tissue surface in W/cm², exposure duration, resulting radiant exposure in J/cm², duty cycle if pulsed, beam geometry and spot size, and the distance and medium between source and tissue.

Published practice gives useful anchors. Zheng and colleagues, in RSC Advances, report graphene oxide and reduced graphene oxide nanocomposite photothermal therapy performed at a power density of 0.15 W/cm² — a figure quoted as a power density precisely because that is the transferable quantity. Where the photothermal or photodynamic agent is itself a nanomaterial, the characterisation expectations of the nano-biomaterials page apply in full alongside the optical ones, and the agent’s optical absorption spectrum must be reported in the dispersion medium used.

Two measurement points are routinely confused. Irradiance measured at the source aperture is not irradiance at the tissue, and the difference can be large across an air gap, a window or a coupling medium. The location of the measurement, the instrument used and the date of its calibration should be stated.

Maturity of emitter technology

The maturity of the underlying light-source technology is relevant, because device papers often implicitly assume that laboratory efficiency transfers to a usable device area. Sun and colleagues, in Light: Advanced Manufacturing, review perovskite light-emitting diodes toward commercial full-colour displays and report the area dependence directly: a blade-coated device reached 22.5% external quantum efficiency at 102 mm² and 21.46% at 900 mm², while a large-area green perovskite LED reached a maximum external quantum efficiency of 16.4% over an active area of up to 9.0 cm² 3,10. The decline with area is modest between 102 and 900 mm² and more pronounced at centimetre scale, and the authors frame the remaining obstacles to commercialisation as technical rather than solved 10.

For biomedical work, this is relevant in two respects. A device that must illuminate a tissue area of several square centimetres cannot assume the efficiency figures quoted for millimetre-scale test structures, which affects the power budget and therefore the thermal budget. In addition, the dense micro-LED array approach reported by Huang and colleagues — 900 thin-film micro-LEDs in 2 × 2 cm² — is in part a response to this problem, achieving area coverage and uniformity from many small high-efficiency emitters rather than one large one 3.

Reported performance of biomedical and biomedically relevant optoelectronic devices

DeviceReported performanceWhat the figure is conditional onSource
Skin-like optoelectronic health patch16.5 mW total power consumption under 30% tensile strainMeasured under strain, which is the operationally relevant condition; power at rest would be lower and less informativeHuang et al., Journal of Semiconductors
Uniform area-source patch900 thin-film micro-LEDs integrated in a 2 × 2 cm² areaDensity is the means of achieving optical uniformity on a curved surface; it also sets the thermal loadHuang et al., Journal of Semiconductors
Brain-implanted micro-ILEDTemperature rise below 0.1 degrees CAt 20 Hz stimulation; higher frequency, pulse width or optical power raises the thermal loadHuang et al., Journal of Semiconductors
Blade-coated perovskite LED22.5% external quantum efficiency at 102 mm²; 21.46% at 900 mm²Efficiency falls as active area rises; these are display-oriented devices, not biomedically qualified onesSun et al., Light: Advanced Manufacturing
Large-area green perovskite LED16.4% maximum external quantum efficiency over an active area up to 9.0 cm²The centimetre-scale penalty relative to millimetre-scale test structuresSun et al., Light: Advanced Manufacturing
Self-powered flexible triboelectric nanogenerator74.3 V maximum output voltageA peak open-circuit figure; usable power depends on load, matching and motion inputWu, Wang and Shen, Journal of Materials Chemistry C
Graphene oxide nanocomposite photothermal therapy0.15 W/cm² power densityQuoted as power density at the tissue, which is the transferable quantity; wavelength and duration still requiredZheng et al., RSC Advances

Figures as reported in each source. They come from different device classes, measurement conditions and development stages and are not directly comparable; they are shown together to make the conditional nature of each figure visible, not to rank the technologies.

Required content of the methods section

The preceding considerations amount to a reporting standard that is not yet conventional in this literature, which is why Lee and colleagues could include only 15 of 639 screened papers 19. For an emitting device: wavelength with bandwidth, irradiance at the tissue with the measurement point and instrument, duty cycle, total exposure, beam geometry, and thermal measurement or thermal control. For a detecting device: detector type and spectral response, active area, source–detector separation and geometry, contact pressure, sampling rate, filtering applied, and the reference method the device was validated against with the agreement statistics. For both: the participant or tissue characteristics that modulate the optical path — skin tone on a stated scale, measurement site, perfusion state, and for animal work the tissue depth.

The comparison below presents the methods paragraph of a wearable sensing study, which is where the gap between what was done and what was written is usually widest. A parallel discipline applies on the materials side; see material selection for medical devices.

The methods paragraph of a wearable optical sensing study, two ways

Cannot be compared or reproduced

A custom reflectance photoplethysmography sensor using red and infrared LEDs and a silicon photodiode was placed on the wrist. Signals were acquired, filtered and processed to extract heart rate and oxygen saturation. Measurements were compared against a commercial pulse oximeter in healthy volunteers and showed good agreement.

Which wavelengths, and how narrow? “Red and infrared” is a band name, not a parameter, and bandwidth affects the absorption ratio.

What geometry? Source–detector separation sets the sampled tissue depth and is unstated, so the measurement cannot be replicated.

What irradiance, measured where? No optical dose, no measurement point, no calibration — so neither the signal nor the safety can be assessed.

What contact pressure? Pressure changes perfusion and therefore the waveform; it is a known confounder left uncontrolled.

Which skin tones? “Healthy volunteers” conceals the variable most likely to limit generalisability.

What does “good agreement” mean? No bias, no limits of agreement, no range over which the comparison holds.

Can be

A custom reflectance photoplethysmography sensor used two surface-mount LEDs at 660 nm and 940 nm, each with a full width at half maximum of 20 nm, and a silicon photodiode of 7.5 mm2 active area with a spectral response of 400 to 1100 nm, at a centre-to-centre source-detector separation of 6 mm. Irradiance at the skin surface was 1.8 mW/cm2 per channel, measured with a calibrated power meter at the sensor window (calibration traceable, last verified three months before the study). LEDs were driven at 100 Hz with a 5% duty cycle, time-multiplexed. The sensor was held on the volar wrist by a strap tensioned to 20 mmHg, verified with a pressure film. Signals were sampled at 500 Hz with 16-bit resolution, bandpass filtered from 0.5 to 8 Hz with a fourth-order zero-phase Butterworth filter, and heart rate was extracted by the peak-detection algorithm described in the supplement. Thirty-two volunteers were recruited (18 women, age 22 to 64 years) with Fitzpatrick skin types I to VI, at least four participants per type. The reference was a finger transmittance pulse oximeter (model and software version stated in the supplement) sampling simultaneously. Agreement is reported as Bland-Altman bias and 95% limits of agreement for heart rate and for saturation, overall and stratified by Fitzpatrick type, with the per-stratum sample sizes given; the saturation comparison is limited to the 94 to 100% range observed, and no claim is made below it.

Wavelengths are given with bandwidth, and the detector with its active area and spectral response, so the optical configuration is defined.

Geometry and duty cycle are specified, which fixes both the sampled tissue volume and the delivered optical dose.

Irradiance is given with its measurement point, instrument and calibration currency — at the window, not at the LED.

Contact pressure is specified and verified, removing a known confounder rather than assuming it to be constant.

Skin tone is reported on a named scale with a minimum per stratum, and results are stratified by it.

Agreement is reported as bias and limits of agreement over a stated range, with the explicit limitation that saturation was not tested below 94%.

The second version is longer but contains no new experiment: every item is a setting that the authors had already chosen or a characteristic that was already recorded. What it gains is eligibility for inclusion: a device reported in this way can be used in a systematic review, which is the difference between the 15 papers Lee and colleagues could include and the 624 they could not.

Unresolved questions

Photoplethysmography accuracy across skin tones is not resolved. Kim and Baek, in Electronics, identify it as a current limitation, and Lee and colleagues’ systematic review of 639 screened papers could include only 15, which means the comparable evidence base for skin-compatible wearable sensors is small 11,19. No source here supports a general claim that a given wearable performs equivalently across skin tones; a study that does not stratify should state this explicitly.

Long-term stability of flexible and implanted optoelectronics is similarly open. Cho and colleagues treat lifetime and encapsulation of flexible OLEDs under mechanical and moisture stress as unresolved; Metuh and colleagues treat power transfer and thermal management in wireless implants the same way 4,6. Reported performance figures in this field are overwhelmingly short-term, and a paper that reports a figure after one month of operation has reported an unusual result and should state this.

Blood-pressure estimation from photoplethysmographic waveform features is an area in which enthusiasm exceeds the evidence in the sources available here. Kim and Baek discuss it among future directions rather than established capability 11. A correlation in a small cohort should be treated as hypothesis-generating, and the reference method, the blood-pressure range of the cohort and the agreement limits should be reported rather than only a correlation coefficient.

Finally, the perovskite emitter figures above are display-oriented. Sun and colleagues report efficiency and area, not operational lifetime under biomedical duty cycles or biocompatibility of the encapsulated device, and neither can be inferred from an efficiency number 10. The concepts and definitions hub places these device terms alongside the drug-side equivalents in material selection for drug development, active pharmaceutical ingredients and bio-macromolecules.

Key points

Key points

Biomedical optoelectronics divides into detection, emission and integrated systems, and in each case the reportable quantities are optical rather than electrical. Wavelength selection follows tissue absorption — 660 nm and 940 nm in pulse oximetry, within a silicon photodiode range of 190 to 1100 nm. Flexible devices have reached 16.5 mW under 30% strain and arrays of 900 micro-LEDs in 2 × 2 cm², and an implanted micro-ILED has shown a temperature rise below 0.1 degrees C at 20 Hz; all are conditional figures that are meaningful only with their conditions stated. Efficiency does not scale freely with area, skin tone remains an unresolved limitation in optical sensing, and long-term stability data are scarce. Wavelength, irradiance at the tissue with its measurement point, duty cycle, geometry, contact conditions and skin tone distribution should be reported; otherwise the work cannot be compared with other studies.

Application to your study

Application to your study

  1. Report wavelength with bandwidth rather than a colour name. Centre wavelength and full width at half maximum for every source.
  2. Report irradiance at the tissue, with the measurement point and instrument. W/cm² at the window or skin surface, not drive power, with the calibration date of the meter.
  3. State the duty cycle and total exposure. Frequency, pulse width and duration should be stated, from which radiant exposure in J/cm² can be calculated, and the calculated value should be reported.
  4. Specify the optical geometry. Source–detector separation for reflectance sensing, spot size and beam profile for therapy, distance and intervening medium in both cases.
  5. Control and report contact pressure for any skin-mounted sensor. Pressure alters perfusion and the waveform; the value and the method of verification should be stated.
  6. Report skin tone on a named scale, with a minimum number per stratum, and stratify the results. Where stratification is not possible, the report should state that the study does not support a claim across skin tones.
  7. Include a thermal measurement or a thermal control for any emitting device. For optogenetics, stimulation in opsin-negative animals; for phototherapy, surface temperature during exposure.
  8. Name the reference method and report agreement properly. Bias and 95% limits of agreement over the range actually observed, not a correlation coefficient.
  9. Avoid extrapolating efficiency across device area. Where a design requires several square centimetres, figures at that area should be cited or the scaling stated as unverified.
  10. State the duration of device operation. Short-term performance data are the norm in this field; stability data beyond a few days constitute a result that merits presentation as such.

Frequently asked questions

Because oxyhaemoglobin and deoxyhaemoglobin absorb light differently on either side of their isosbestic point, comparing the pulsatile absorption at two wavelengths on opposite sides of it yields a ratio that maps onto arterial oxygen saturation. Lee and colleagues, in Applied Sciences, report 660 nm red and 940 nm infrared as the wavelengths typically used, and note that silicon photodiodes respond across 190 nm in the ultraviolet to 1100 nm in the infrared, so both wavelengths lie well within a single detector’s range. The practical reporting point is that these are specific wavelengths with a bandwidth, not a choice of “red and infrared” — bandwidth affects the absorption ratio and therefore the calibration.

Seven items: wavelength with spectral bandwidth; irradiance at the tissue surface in W/cm², with the point of measurement and the instrument and its calibration currency; exposure duration; the resulting radiant exposure in J/cm²; duty cycle if the source is pulsed; beam geometry and spot size; and the distance and medium between source and tissue. Zheng and colleagues, in RSC Advances, report graphene oxide nanocomposite photothermal therapy at 0.15 W/cm², quoted as a power density because that is the quantity that transfers between studies. Drive power or LED wattage is not a dose and cannot be converted into one without the geometry.

Not necessarily; the operating conditions matter more than the device itself. Huang and colleagues, in the Journal of Semiconductors, report a brain-implanted micro-ILED with a temperature rise below 0.1 degrees C at 20 Hz stimulation. That is well within the range where thermal confounding is unlikely, but it is specific to that duty cycle: increasing pulse frequency, pulse width or optical power increases the thermal load, and heat deposition is also geometry-dependent. For this reason an optogenetics methods section must state frequency, pulse width and total stimulation duration, and should include a thermal control such as identical stimulation in opsin-negative animals, so an observed effect can be attributed to the optical stimulus.

The question remains unresolved in the available evidence. Kim and Baek, in Electronics, name performance variation across skin tones among the current limitations of photoplethysmography in wearable devices, alongside motion artefact and contact pressure dependence. Lee and colleagues’ systematic review of skin-compatible wearable sensors screened 639 papers across five databases and could include only 15, so the comparable evidence base is small. No source here supports a claim of equivalent performance across tones. Where a study has not stratified by a named skin-tone scale with adequate numbers per stratum, that limitation should be stated explicitly rather than pooled accuracy figures being presented.

Not reliably. Sun and colleagues, in Light: Advanced Manufacturing, report a blade-coated perovskite LED at 22.5% external quantum efficiency over 102 mm² and 21.46% over 900 mm² — a modest decline — while a large-area green perovskite LED reached a maximum of 16.4% over an active area of up to 9.0 cm². The penalty becomes material at centimetre scale, which is the scale most biomedical illumination needs. One practical response is many small emitters rather than one large one: Huang and colleagues report 900 thin-film micro-LEDs integrated in a 2 × 2 cm² patch, achieving area coverage and uniformity from high-efficiency individual devices.

It is an active direction with demonstrated components rather than a finished capability. Wu, Wang and Shen, in the Journal of Materials Chemistry C, report a self-powered flexible triboelectric nanogenerator reaching a maximum output voltage of 74.3 V, and frame continuous flexible photoplethysmographic monitoring against the roughly 15 million cardiovascular deaths worldwide each year. The voltage figure requires careful interpretation: a peak open-circuit voltage is not usable power, which depends on load matching, the motion input available and the rectification and storage stage. The relevant comparison is against the device power budget — Huang and colleagues report a skin-like optoelectronic patch at 16.5 mW under 30% tensile strain.

Their strengths and limitations differ. OLEDs are intrinsically flexible, emit diffusely over an area and conform well to skin, which Cho and colleagues treat as their attraction in Materials Horizons; their limitations are luminance, operational lifetime and sensitivity to moisture and mechanical stress, all of which put weight on encapsulation. Inorganic micro-LEDs are far brighter per unit area, stable and small enough to implant, which is why Huang and colleagues cover them for implantable optogenetics and theranostics in the Journal of Semiconductors; achieving area coverage requires integrating many of them, as in their 900-device 2 × 2 cm² array. The choice depends on whether diffuse surface illumination or localised high-intensity delivery is required.

The sources available here treat it as a future direction rather than an established capability — Kim and Baek discuss it in that framing in Electronics. Waveform features do carry haemodynamic information, but the mapping to absolute pressure depends on vascular properties that differ between individuals and change within an individual, and small-cohort correlations have historically not held up on independent validation. Such work should be reported as hypothesis-generating, with the reference method and its own accuracy named, the blood-pressure range actually spanned by the cohort reported, and Bland-Altman bias and limits of agreement given rather than a correlation coefficient.

Usually unreported, which is itself informative. Cho and colleagues treat lifetime and encapsulation of flexible OLEDs under mechanical and moisture stress as unresolved, and Metuh, Petersen and Ou treat power transfer and thermal management in wireless optoelectronic implants the same way in Laser & Photonics Reviews. The performance figures that circulate in this literature are overwhelmingly short-term measurements on freshly fabricated devices. For an implanted device, stability is also a materials and biological evaluation question governed by contact type and duration under ISO 10993-1, with biodegradation testing treated as essential beyond 30 days of implantation. Operational data over periods of weeks, where available, should be presented as a finding.

References

  1. U.S. Food and Drug Administration (CDRH, CBER). Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process". U.S. Food and Drug Administration. 2023. read 9 October 2026. fda.gov
  2. International Council for Harmonisation; U.S. Food and Drug Administration (CDER/CBER). Guidance for Industry Q8(R2) Pharmaceutical Development. U.S. Department of Health and Human Services, Food and Drug Administration. 2009;Revision 2. read 9 October 2026. fda.gov
  3. Huang Y, Liu H, Lin Y, Hu J, Zou L, Chen S, Chen O, Yi X, Wang L. Micro-LEDs in biomedicine: from implantable optogenetics to intelligent theranostics. Journal of Semiconductors. 2026;47(8):081606. doi:10.1088/1674-4926/26050037 read 9 October 2026. doi.org/10.1088/1674-4926/26050037
  4. Cho EH, Kim YW, Sim J, Yeon H, Baek S, Jeong SM, Lee J, Jeon Y, Choi KC. Recent advances in flexible and wearable OLEDs for biomedical applications: a review. Materials Horizons. 2025. doi:10.1039/D5MH00742A read 9 October 2026. doi.org/10.1039/D5MH00742A
  5. Daniel SA, Suya Prem Anand P, Jesuarockiam N, Tabrej K, Shabir Hussain K. Advancement in biomedical implant materials-a mini review. Frontiers in Bioengineering and Biotechnology. 2024;12. doi:10.3389/fbioe.2024.1400918 read 9 October 2026. doi.org/10.3389/fbioe.2024.1400918
  6. Metuh P, Petersen PM, Ou Y. Recent Advances in Wireless Optoelectronic Biomedical Implants. Laser & Photonics Reviews. 2024;18(12):2300752. doi:10.1002/lpor.202300752 read 9 October 2026. doi.org/10.1002/lpor.202300752
  7. Everhart AO, Sen S, Stern AD, et al. Association between regulatory submission characteristics and recalls of medical devices receiving 510(k) clearance. JAMA. 2023;329:144-156. read 9 October 2026. tctmd.com
  8. Al-Zyoud W, Haddadin D, Hasan SA, Jaradat H, Kanoun O. Biocompatibility Testing for Implants: A Novel Tool for Selection and Characterization. Materials. 2023;16(21):6881. doi:10.3390/ma16216881 read 9 October 2026. doi.org/10.3390/ma16216881
  9. Wu W, Wang L, Shen G. Flexible photoplethysmographic sensing devices for intelligent medical treatment. Journal of Materials Chemistry C. 2023;11:97-112. doi:10.1039/D2TC03318F read 9 October 2026. doi.org/10.1039/D2TC03318F
  10. Sun C, Jiang Y, Wei K, Yuan M. Perovskite light-emitting diodes toward commercial full-colour displays: progress and key technical obstacles. Light: Advanced Manufacturing. 2023;4(3):272-291. doi:10.37188/lam.2023.015 read 9 October 2026. doi.org/10.37188/lam.2023.015
  11. Kim KB, Baek HJ. Photoplethysmography in Wearable Devices: A Comprehensive Review of Technological Advances, Current Challenges, and Future Directions. Electronics. 2023. doi:10.3390/electronics12132923 read 9 October 2026. doi.org/10.3390/electronics12132923
  12. Hoogervorst LA, Geurkink TH, Lubbeke A, et al. Quality and Utility of European Cardiovascular and Orthopaedic Registries for the Regulatory Evaluation of Medical Device Safety and Performance Across the Implant Lifecycle: A Systematic Review. International Journal of Health Policy and Management. 2023;12(1):1-11. doi:10.34172/ijhpm.2023.7648 read 9 October 2026. doi.org/10.34172/ijhpm.2023.7648
  13. Kearney B, McDermott O. The Challenges for Manufacturers of the Increased Clinical Evaluation in the European Medical Device Regulations: A Quantitative Study. Therapeutic Innovation & Regulatory Science. 2023. doi:10.1007/s43441-023-00527-z read 9 October 2026. doi.org/10.1007/s43441-023-00527-z
  14. Kadakia KT, Dhruva SS, Caraballo C, et al. Use of recalled devices in new device authorizations under the US Food and Drug Administration's 510(k) pathway and risk of subsequent recalls. JAMA. 2023;329:136-143. read 9 October 2026. tctmd.com
  15. Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Explanation and Elaboration: A report of the ISPOR CHEERS II Good Practices Task Force. Value in Health. 2022;25(1):10-31. read 9 October 2026. ispor.org
  16. Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations. BMJ. 2022;376:e067975. read 9 October 2026. cris.iucc.ac.il
  17. Zhao H. Optogenetic Implants. Handbook of Biochips. 2022:179-206. doi:10.1007/978-1-4614-3447-4_48 read 9 October 2026. doi.org/10.1007/978-1-4614-3447-4_48
  18. Zheng X, Zhang P, Fu Z, Meng S, Dai L, Yang H. Applications of nanomaterials in tissue engineering. RSC Advances. 2021;11:19041-19058. doi:10.1039/d1ra01849c read 9 October 2026. doi.org/10.1039/d1ra01849c
  19. Lee I, Park N, Lee H, Hwang C, Kim JH, Park S. Systematic Review on Human Skin-Compatible Wearable Photoplethysmography Sensors. Applied Sciences. 2021;11(5):2313. doi:10.3390/app11052313 read 9 October 2026. doi.org/10.3390/app11052313
  20. Wouters OJ, McKee M, Luyten J. Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018. JAMA. 2020;323(9):844-853. doi:10.1001/jama.2020.1166 read 9 October 2026. doi.org/10.1001/jama.2020.1166
  21. Kang CW, Fang FZ. State of the art of bioimplants manufacturing: part I. Advances in Manufacturing. 2018;6:20-40. doi:10.1007/s40436-017-0207-4 read 9 October 2026. doi.org/10.1007/s40436-017-0207-4
  22. Muskens IS, Gupta S, Hulsbergen A, Moojen WA, Broekman MLD. Introduction of Novel Medical Devices in Surgery: Ethical Challenges of Current Oversight and Regulation. Journal of American College of Surgeons. 2017;225:558-565. read 9 October 2026. scholarlypublications.universiteitleiden.nl
  23. Tang Z, He C, Tian H, Ding J, Hsiao BS, Chu B, Chen X. Polymeric nanostructured materials for biomedical applications. Progress in Polymer Science. 2016;60:86-128. doi:10.1016/j.progpolymsci.2016.05.005 read 9 October 2026. doi.org/10.1016/j.progpolymsci.2016.05.005
  24. Mitera G, Swaminath A, Rudoler D, Seereeram C, Giuliani M, Leighl N, Gutierrez E, Dobrow MJ, Coyte PC, Yung T. Cost-Effectiveness Analysis Comparing Conventional Versus Stereotactic Body Radiotherapy for Surgically Ineligible Stage I Non-Small-Cell Lung Cancer. JCO Oncology Practice. 2014;10(3):e130-e136. doi:10.1200/jop.2013.001206 read 9 October 2026. doi.org/10.1200/jop.2013.001206
  25. Johnson J, Rogers W. Innovative surgery: The ethical challenges. Journal of Medical Ethics. 2012;38(1):9-12. doi:10.1136/jme.2010.042150 read 9 October 2026. doi.org/10.1136/jme.2010.042150
  26. Hasirci V, Vrana E, Zorlutuna P, Ndreu A, Yilgor P, Basmanav FB, Aydin E. Nanobiomaterials: a review of the existing science and technology, and new approaches. Journal of Biomaterials Science, Polymer Edition. 2006;17(11):1241-1268. doi:10.1163/156856206778667442 read 9 October 2026. doi.org/10.1163/156856206778667442

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 9). Applications of Optoelectronic Devices in Biomedicine: Imaging, Sensing and Phototherapy. Pubrica. https://pubrica.com/academy/concepts-definitions/applications-of-optoelectronic-devices/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

Optical reporting block for a device methods section

The sections that apply to the device should be completed before drafting. The irradiance, duty cycle and skin-tone rows are those most often missing, and their absence is the reason optical device papers are excluded from systematic reviews.

OPTICAL DEVICE REPORTING BLOCK

Device role: [ ] detection  [ ] emission  [ ] integrated source + detector
Setting: [ ] skin-mounted  [ ] implanted  [ ] benchtop / ex vivo  [ ] in vitro

1. SOURCE  (one block per source)
   Type ............................... [ ] LED  [ ] micro-LED  [ ] OLED
                                        [ ] laser diode  [ ] other ____________
   Centre wavelength .................. ______ nm   FWHM ______ nm
   Drive current / voltage ............ ______________
   Irradiance AT THE TISSUE ........... ______ mW/cm2
       Measurement point ............... [ ] sensor window  [ ] skin surface
                                         [ ] source aperture (state the gap)
       Instrument ...................... ______________________________
       Calibration last verified ....... ____ / ____ / ______
   Modulation ......................... frequency ______ Hz
                                        pulse width ______
                                        duty cycle ______ %
   Total exposure duration ............ ______
   Radiant exposure (calculated) ...... ______ J/cm2
   Beam geometry / spot size .......... ______________________________
   Intervening medium ................. ______________________________

2. DETECTOR
   Type and material .................. ______________________________
   Active area ........................ ______ mm2
   Spectral response range ............ ______ to ______ nm
   Optical filtering .................. ______________________________
   Source-detector separation ......... ______ mm (centre to centre)
   Configuration ...................... [ ] reflectance  [ ] transmittance

3. CONTACT AND SITE
   Measurement site ................... ______________________________
   Contact pressure ................... ______ mmHg, verified by ____________
   Coupling medium / adhesive ......... ______________________________
   Mechanical condition tested ........ [ ] at rest  [ ] under ______ % strain
                                        [ ] during motion, described: ____________

4. SIGNAL CHAIN
   Sampling rate ______ Hz   Resolution ______ bits
   Filtering (type, order, band, phase) ______________________________
   Artefact rejection rule ............ ______________________________
   Feature extraction algorithm ....... [ ] described in text  [ ] code available at ______

5. THERMAL  (mandatory for any emitting device)
   Temperature measured ............... [ ] yes, ______ by ______________
                                        [ ] no
   Maximum rise observed .............. ______ degrees C at ______ Hz
   Thermal control included ........... [ ] opsin-negative / sham stimulation
                                        [ ] source off, same handling
                                        [ ] none (state the limitation)

6. PARTICIPANTS OR TISSUE
   n ______   Age range ______   Sex distribution ______
   Skin tone scale used ............... ______________________________
   n per stratum ...................... ______________________________
   Perfusion / temperature state ...... ______________________________
   For animal or ex vivo work: tissue, depth, preparation ______________

7. VALIDATION
   Reference method, model, software version ______________________________
   Simultaneous acquisition? .......... [ ] yes  [ ] no
   Range actually spanned by the reference ______________
   Agreement reported as ............... [ ] Bland-Altman bias + 95% LoA
                                         [ ] stratified by skin tone
                                         [ ] correlation only (not sufficient)

8. DURATION AND STABILITY
   Operating time covered by the data . ______________
   Repeat characterisation after use? . [ ] yes, result ______________  [ ] no
   For implants: intended duration ______ days
       If more than 30 days, biodegradation and long-term biological
       evaluation addressed? [ ] yes  [ ] no

9. WHAT NOT TO CLAIM
   [ ] No cross-skin-tone generalisation without stratified data
   [ ] No absolute blood-pressure claim from waveform features alone
   [ ] No efficiency extrapolation from a smaller device area
   [ ] No long-term stability claim from short-term measurements

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

Pubrica’s medical writing teams prepare reports of optical and optoelectronic device studies in which the optical parameters are complete — wavelength with bandwidth, irradiance at the tissue with its measurement point and calibration, duty cycle, geometry, contact conditions and thermal data — and in which validation is reported as agreement rather than correlation. This completeness determines whether a device paper can be included in a systematic review.

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Pubrica reviews device studies together with their raw acquisition settings and identifies the optical parameters that reviewers are likely to find missing.

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.